Idarucizumab, which was granted Breakthrough Therapy Designation by the FDA, was shown to restore the blood clotting mechanism in healthy volunteers1,2 This is the first time that such an effect was ...

One of the hallmarks of COVID-19, the disease caused by SARS-CoV-2, is a multi-organ system process characterized by the formation of blood clots in small vessels. What was most puzzling in the early ...

The glycoprotein V of the blood platelets is an important switch point for haemostasis and thrombus formation. This new finding could have great clinical potential. When our blood vessels are injured ...

Researchers from the University of Birmingham, UK, who identified a novel mechanism for platelet activation in pathogenic blood clotting (thrombosis) are now turning their attention to sepsis.

A bioengineer has endowed platelets with extra powers to make the clotting process more resilient in the face of trauma. If it's proven to work in clinical situations, such 'superplatelets' might ...

Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain. But scientists at Uppsala University and the University Hospital have now identified a mechanism they believe to be ...